Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 2
  • 5
  • 11
  • 5
  • 1
  • 10

Found 11 Thrombosis trials

A listing of Thrombosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS-IgAN)

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS-IgAN)

18-80 years
All genders
Phase 3
This study will use a new investigational study drug called OMS721 in people with Immunoglobulin A (IgA) Nephropathy. This kidney disease produces abnormal amounts of a protein called IgA in the kidney that damage the filtering units or glomeruli. Glomeruli are tiny filtering units in the kidney that remove excess …
 Continuation of the nuMoM2b Heart Health Study

Continuation of the nuMoM2b Heart Health Study (nuMoM2b-HHS2)

18-99 years
Female
Interventional
The nuMoM2b Heart Health Study (nuMoM2b-HHS) has followed a demographically diverse cohort of women enrolled and richly phenotyped during their first pregnancy, with data and biospecimens prospectively collected for up to 7 years thereafter. The overarching scientific goal of this study is to define the relationship between adverse pregnancy outcomes …
 PEERLESS Study

PEERLESS Study

All genders
The FlowTriever Retrieval/Aspiration System (referred to as “FlowTriever”) is an FDA-cleared device designed to treat pulmonary embolism (PE). A PE is a blood clot trapped in your lung. The FlowTriever is used to remove the clot by pulling it into a catheter so that the clot can be removed from …
 Trial to Optimize Patients Selection for Endovascular Treatment in Acute Ischemic Stroke

Trial to Optimize Patients Selection for Endovascular Treatment in Acute Ischemic Stroke

All genders
Stroke can occur when a clot stops the flow of the blood in one of the arteries supplying the brain. This type of stroke, called ischemic stroke, can be treated alone or in a combination of drugs to dissolve the clot, devices to remove the clot (mechanical thrombectomy) or use …

BOLT: A Prospective muliticenter study of patients with Deep Vein Thrombosis to Evaluate the Safety and Efficacy of Indigo Aspiration

18-99 years
All genders
Interventional
The purpose of this study is to observe the safety and effectiveness of the Indigo Aspiration System. This study will help determine how study participants recover when the study device is used to remove the clot from the deep veins.
 NONCOMPACT- International Consortium for Multimodality Phenotyping in Adults with Non-compaction

NONCOMPACT- International Consortium for Multimodality Phenotyping in Adults with Non-compaction

18-99 years
All genders
This is a prospective, multicenter observational study to identify clinical, genetic and imaging predictors of clinical outcome in patients with suspected non-compaction cardiomyopathy Many healthy people have increased trabeculations without consequences, however, some may develop blood clots, heart rhythm disorders or heart failure later in life. Currently we cannot predict …

Study to Determine the Safety of Drug RNS60 in Large Vessel Occlusion Stroke Patients

18-99 years
All genders
Phase 2
Interventional
Endovascular therapy is the physical removal of the clot in your brain through an artery in your groin or arm. This type of stroke is called an ischemic stroke and carries a high risk of disability or death. In this study we are trying to learn more about a new …

WEB PAS

All genders
The primary objective of this post-market surveillance study is to evaluate the long-term safety and effectiveness of the WEB® Device within currently approved indications for use. Key effectiveness outcome is the proportion of subjects with adequate aneurysm occlusion at one year after treatment. Key safety outcome includes the proportion of …

Antiplatelet Removal and HemocompatIbility Events with the HeartMate 3 Pump

All genders
The HeartMate 3 requires medicines to keep your blood from clotting knowing as “blood thinners” which can both be anticoagulants and antiplatelet drugs. The standard drugs given when you have the HeartMate 3 are warfarin and aspirin. This study is investigating whether the combination of these drugs as compared to …
1 - 10 of 11